Oncology CRO Email us info@sms-oncology.com
Follow us on
SMS-oncology

The 4D oncology CRO

Drug – Data – Dossier

The path to successful development of oncology drugs is geared by generation of clinical data that builds up a compliant regulatory dossier. Oncology drug development is complex and direction is required to navigate a safe passageway by avoiding risks and leveraging opportunities to increase the chances of success.

Direction

SMS-oncology adds an extra dimension to clinical cancer research by providing direction to our sponsors. During the study we turn complex data into meaningful insights using our oncology expertise. This information helps our sponsors to make informed decisions, stay in control, mitigate risks, identify opportunities and collect the right data to build the regulatory dossier. SMS-oncology: an oncology CRO adding value by providing direction.

Our oncology services

Clinical operations Read more

Clinical operations

From initiation and implementation to completion of oncology clinical trials with a specialization in:
• Early phase oncology trials
• Immuno-oncology trials
Read more...

Consultancy Read more

Consultancy

From strategic expert advice on oncology drug development and trial design to protocol writing and scientific advisory boards.
Read more...

Integrated services Read more

Integrated services

From upfront strategic advice translated into clinical operations to frequent meaningful insights during study conduct.
Read more...

Our advantages

Responsiveness, Quality & Flexibility
  • Responsive and "right-sized" project teams for close collaboration, flexibility and fast-decision making
  • Close and personal involvement of the management team ensuring a high standard of quality
  • Delivering tailor made solutions by offering full or functional services as needed
Oncology Experts
  • In-depth knowledge of the complex nature of early phase oncology and immuno-oncology studies
  • Dedicated professionals with oncology know-how and experience in all functions of the company
  • Extensive network of Key Opinion Leaders throughout Europe
Direction
  • Proactively addressing challenges before they turn into hurdles
  • Strategic clinical development advice that can be directly translated into clinical operations
  • Turning complex data into meaningful insights during study conduct using our oncology expertise

News

26 January 2015

"Put to the Test", an article by Lindy Bosch and Raymond Hoffmans published in the January issue of EBR, outlines what a typical oncology Phase I study looks like nowadays.

21 January 2015

SMS-oncology launches new website and 4D’s: Drug, Data, Dossier, Direction

12 January 2015

SMS-oncology is proud supporter of the Targeted Anticancer Therapies (TAT) congress 2015, 2-4 March in Paris.

Conference schedule

Recent blog posts